Open AccessManagement of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma
Author(s) -
Kinnosuke Matsumoto,
Takayuki Shiroyama,
Kotaro Miyake,
Yuji Yamamoto,
Tomoki Kuge,
Midori Yoneda,
Makoto Yamamoto,
Yujiro Naito,
Yasuhiko Suga,
Kiyoharu Fukushima,
Shohei Koyama,
Kota Iwahori,
Haruhiko Hirata,
Izumi Nagatomo,
Yoshito Takeda,
Atsushi Kumanogoh
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028476
Subject(s) - lenvatinib , medicine , tolerability , blood pressure , oncology , cancer , adverse effect , thyroid cancer